Genmab A/S (OTCMKTS:GNMSF) Stock Crosses Below 200 Day Moving Average - Here's What Happened

Genmab A/S (OTCMKTS:GNMSF - Get Free Report) shares passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $216.46 and traded as low as $191.13. Genmab A/S shares last traded at $191.13, with a volume of 1 shares changing hands.

Genmab A/S Trading Down 2.6 %

The stock has a market cap of $12.30 billion, a price-to-earnings ratio of 10.63 and a beta of 1.08. The firm has a fifty day simple moving average of $205.72 and a 200-day simple moving average of $214.87.

Genmab A/S (OTCMKTS:GNMSF - Get Free Report) last issued its quarterly earnings results on Wednesday, February 12th. The company reported $5.70 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.46 by $5.24. Genmab A/S had a return on equity of 19.75% and a net margin of 36.30%.

Genmab A/S Company Profile

Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; and Amivantamab for advanced or metastatic gastric or esophageal cancer and NSCLC.